Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to evaluate the efficacy of a polypill strategy containing aspirin (100 mg), ramipril (2.5, 5 or 10 mgs), and atorvastatin (40 mgs) compared with the standard of care (usual care according to the local clinical practices at each participating country) in secondary prevention of major cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in elderly patients with a recent myocardial infarction.
Epistemonikos ID: 73124858433239a09e0c4bef37735388e43caa60
First added on: May 12, 2024